Access count of this item: 39

Files in This Item:
File Description SizeFormat 
molecules24030429.pdf4.44 MBAdobe PDFView/Open
Title: Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy
Authors: Asamitsu, Sefan
Obata, Shunsuke
Yu, Zutao
Bando, Toshikazu
Sugiyama, Hiroshi
Author's alias: 朝光, 世煌
小幡, 俊介
余, 祖滔
板東, 俊和
杉山, 弘
Keywords: cancer therapy
telomere
oncogenes
G-quadruplex
selective ligands
Issue Date: 24-Jan-2019
Publisher: NLM (Medline)
Journal title: Molecules
Volume: 24
Issue: 3
Thesis number: 429
Abstract: A G-quadruplex (G4) is a well-known nucleic acid secondary structure comprising guanine-rich sequences, and has profound implications for various pharmacological and biological events, including cancers. Therefore, ligands interacting with G4s have attracted great attention as potential anticancer therapies or in molecular probe applications. To date, a large variety of DNA/RNA G4 ligands have been developed by a number of laboratories. As protein-targeting drugs face similar situations, G-quadruplex-interacting drugs displayed low selectivity to the targeted G-quadruplex structure. This low selectivity could cause unexpected effects that are usually reasons to halt the drug development process. In this review, we address the recent research on synthetic G4 DNA-interacting ligands that allow targeting of selected G4s as an approach toward the discovery of highly effective anticancer drugs.
Rights: © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
URI: http://hdl.handle.net/2433/236180
DOI(Published Version): 10.3390/molecules24030429
PubMed ID: 30682877
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.